Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT04725994
Title Study to Assess the Safety, Tolerability, and Efficacy of IDX-1197 in Combination With XELOX or Irinotecan in Patients With Advanced Gastric Cancer
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors Idience Co., Ltd.
Indications

gastroesophageal junction adenocarcinoma

stomach cancer

Therapies

Irinotecan + Venadaparib

Capecitabine + Oxaliplatin + Venadaparib

Age Groups: adult | senior
Covered Countries USA


No variant requirements are available.